Neogenomics (NEO) earnings, Oct 28, 2026: EPS +133%, stock −0.3%
In brief
Neogenomics reported on Oct 28, 2026. Earnings per share changed +133% year over year, 26.2% above the estimate; revenue +11%. The stock opened with a −4.1% gap and closed the day −0.3% (Oct 29, 2026). The stock is now 18.2% below its 52-week high, +58.1% over 12 months. Next report: Feb 23, 2027.
EPS vs estimate+26.2%
EPS, YoY+133%
Revenue, YoY+11%
Gap · day−4.1% · −0.3%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Jul 28, 2026 | +15.4% | +14.0% |
| Oct 28, 2026 | −4.1% | −0.3% |
Next-quarter estimates, ratings and the NEO chart are in the terminal.
Open the terminalFAQ
When is Neogenomics's next earnings report?
Feb 23, 2027. The date comes from daily data and is corrected if the company moves it.
How did Neogenomics stock react to the report?
Opening gap −4.1%, day's result −0.3%.
Did Neogenomics's earnings grow?
Earnings per share rose 133% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.